HOME >> BIOLOGY >> NEWS
Millennium's LDP(PS)-341 inhibits growth and induces death of cancer cells, appears to overcome chemotherapy resistance

LDP-341 Press release and fact sheet on multiple myeloma:

-Clinical and preclinical data presented at American Society for Hematology Meeting-

-Additional clinical trials planned with National Cancer Institute -

San Francisco, Dec. 4, 2000 -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced the presentation of preclinical and clinical study results demonstrating that an investigational proteasome inhibitor, LDP-341 (formerly PS-341), the first in a new class of anti-cancer agents, is active against multiple myeloma. The latest findings were presented at the 42nd Annual Meeting of the American Society of Hematology (ASH) meeting in San Francisco.

The first presentation, entitled "The Proteasome Inhibitor PS-341 Inhibits Growth, Induces Apoptosis and Overcomes Drug Resistance in Human Multiple Myeloma (MM) Cells," was based on research conducted by Teru Hideshima, M.D., Ph.D., and colleagues at Dana-Farber Cancer Institute and Harvard Medical School in collaboration with Millennium. In the preclinical study, LDP-341, a proprietary small molecule compound, showed in vitro activity against multiple myeloma cells, resulting in the inhibition of cancer cell growth and reproduction, and the inducement of cell suicide (apoptosis), in animals. The potent anti-tumor action of LDP-341 on multiple myeloma cells in these preclinical studies appears to involve both direct (apoptosis) and indirect inhibition of growth factors that promote tumor growth. In addition, in animals LDP-341 appears to increase the effectiveness of other anti-cancer drugs by overcoming cellular resistance, which in humans is a major cause of chemotherapy failure.

Clinical research was presented at the meeting by Thomas Stinchcombe, M.D., and principal investigator Robert Orlowski, M.D., Ph.D., in a report entitled "PS-341 is Active in Multiple Myeloma: Preliminary Report of a Phase I Trial of the Proteasome
'"/>

Contact: Lynn Smiledge, Millennium
617-761-4700
Porter Novelli
4-Dec-2000


Page: 1 2 3 4 5 6

Related biology news :

1. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels
2. The amendment to the law on green Genetic Engineering inhibits innovation and research in Germany
3. Inhibition of cathepsin proteases inhibits tumor formation in transgenic mice
4. Obesity drug inhibits prostate tumor growth
5. Protein inhibits cell growth, may contribute to breast cancer
6. ENBREL combo therapy inhibits joint damage progression, offers significant RA symptom relief
7. Aspirin inhibits ovarian cancer growth, lab study finds
8. UIC chemists identify compound that inhibits cell migration
9. UT Southwestern researchers find protein that both instigates, inhibits heart growth in mice
10. Bile acid inhibits cell death in Huntingtons disease
11. Researchers explain how protein inhibits angiogenesis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
(Date:3/27/2017)... March 27, 2017  Catholic Health Services (CHS) ... Systems Society (HIMSS) Analytics for achieving Stage 6 ... sm . In addition, CHS previously earned a ... using an electronic medical record (EMR). ... level of EMR usage in an outpatient setting.  ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... A ... pregnancy rates in frozen and fresh in vitro fertilization (IVF) transfer ... age to IVF success. , After comparing the results from the fresh and ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... Dr. Bob ... at his local San Diego Rotary Club. The event entitled “Stem ... CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
(Date:10/7/2017)... , ... October 06, 2017 ... ... experience providing advanced instruments and applications consulting for microscopy and surface analysis, ... in application consulting, Nanoscience Analytical offers a broad range of contract analysis ...
Breaking Biology Technology:
Cached News: